Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack)
₹97990*
MRP ₹119500
18% off
₹101575*
MRP ₹119500
15% CB
₹17925 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) belongs to the group of monoclonal antibodies used in the post-exposure treatment of mild to moderate respiratory illness caused by COVID-19 in people aged 12 years or older, weighing at least 40kgs. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) is used in non-hospitalised cases of COVID-19 that are at risk of progressing to severe disease.
Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) contains Casirivimab and Imdevimab which work by using proteins (monoclonal antibodies) that mimic the natural immune system of the body and fight off the harmful virus. They block the virus attachment and entry into the human cells, thereby preventing the progression of the illness.
A qualified healthcare professional will administer Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack). Do not self-administer. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) may cause certain common side effects such as redness, pain and soreness at the injection site. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist.
It is advisable to inform the doctor if you are allergic to any of its components. Consult your doctor if you are pregnant, planning to get pregnant or are breastfeeding. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) is not authorized for use in patients who require oxygen therapy or hospitalisation due to COVID-19.
Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) contains monoclonal antibodies used in the post-exposure treatment of mild to moderate disease caused by SARS-CoV-2. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) works by using monoclonal proteins to imitate the natural defence mechanism of the body. The COVID virus contains a capsid with spike proteins, through which it penetrates into the body cells to cause infection. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) binds to the spike protein of the virus. Thereby blocking the spike protein of the virus from attaching to the human receptor cell and arresting the progress of the disease. Hence, Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) finds use in preventing the progression of mild to moderate covid cases to severe cases requiring hospitalisation. Thus, Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) finds use in reducing rates of hospitalisation. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) may also be used as post-exposure prophylaxis of coronavirus disease in people who are not fully vaccinated against COVID-19, people with immunocompromising conditions, and in those who are at high risk of being exposed to someone with COVID-19.
It is advisable to inform the doctor if you are allergic to any of its components. Keep your doctor informed if you suffer from any chronic diseasea such as HIV, asthma, cancer, liver disease, kidney problems, heart disease, neurodevelopmental disorders, sickle cell disease or if you have recently had surgery, gastrostomy, tracheostomy or positive pressure ventilation. Offer a detailed medical and vaccination history. Discuss any recent vaccinations with the doctor. Inform the doctor especially if you are on any radiotherapy, immunosuppressant drugs, blood thinners or any other medicines. Consult your doctor if you are planning to get pregnant or are breastfeeding. Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) is not meant for use as vaccination and in severe hospitalised cases.
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: No interactions found.
Coronavirus Disease: Coronavirus disease is an infection caused by the SARS-CoV-2 virus. It can range from a mild cold, cough and fever to full-blown pneumonia. Coronavirus belongs to a group of RNA viruses and has crown-like projections on the surface of the pathogen. The virus transmits through droplets generated from an infectious person’s cough, sneeze or heavy breathing. The common symptoms of coronavirus disease are dry cough, tiredness, breathlessness, fever, loss of sense of taste and smell, diarrhoea, body pains, headache, and sore throat.
Country of origin
Keep Refrigerated. Do not freeze.Prepaid payment required.
Alcohol
Caution
It is not recommended to consume alcohol with Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack). Please consult your doctor if you have any concerns.
Pregnancy
Caution
Not enough studies exist to ascertain the effect of Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) on pregnancy. Please consult your doctor if you have any concerns.
Breast Feeding
Caution
Not enough studies exist to ascertain the effect of Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) on nursing. Please consult your doctor in case of any concerns.
Driving
Caution
It is not known if Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) affects your ability to drive. Drive only if you are alert.
Liver
Caution
Exercise caution before using Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) in case of established liver disease. Please consult your doctor to address any concerns.
Kidney
Caution
Exercise caution before using Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) in case of established kidney disease. Please consult your doctor to address any concerns.
Children
Caution
Ronapreve 120 mg/ml Injection 2's (2 Vials Combipack) is not recommended for use in children below 12years. Please consult your doctor if you have any concerns.